Study of the serotonin transporter (SLC6A4) and BDNF genes in French patients with non syndromic mental deficiency

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Tabagh, Refaat ^a   Andres, Christian R ^a,b   Védrine, Sylviane ^a   Cherpi Antar, Catherine ^a   Thepault, Rose Anne ^a   Mignon, Laurence ^c   Dufour Rainfray, Diane ^a   Moraine, Claude ^a   Vourc'h, Patrick ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c NEUROSCIENCE EDUCATION INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; SEROTONIN TRANSPORTER; VALINE; SLC6A4 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; FRANCE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; POPULATION GENETICS; VARIABLE NUMBER OF TANDEM REPEAT; ALLELE; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; RISK;

ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FRANCE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MENTAL RETARDATION; MINISATELLITE REPEATS; ODDS RATIO; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 77649303935     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-30     Document Type: Article

References (46)

1. Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental deficiency: a critical review of recent literature. Dev Med Child Neurol 1997, 39:125-132.
2. Leonard H, Wen X. The epidemiology of mental deficiency: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002, 8:117-134. 10.1002/mrdd.10031, 12216056.
3. Dierssen M, Ramakers GJ. Dendritic pathology in mental deficiency: from molecular genetics to neurobiology. Genes Brain Behav 2006, 5(Suppl 2):48-60. 10.1111/j.1601-183X.2006.00224.x, 16681800.
4. Strobel A, Dreisbach G, Muller J, Goschke T, Brocke B, Lesch KP. Genetic Variation of Serotonin Function and Cognitive Control. J Cogn Neurosci 2007,
5. Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001, 56:479-485. 10.1016/S0361-9230(01)00615-3, 11750793.
6. Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I, Arellano J, DeFelipe J, Gimenez-Amaya JM, Conciatori M, Marino R, Baldi A, Cabib S, Pascucci T, Uhl GR, Murphy DL, Lesch KP, Keller F. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 2001, 21:6862-6873.
7. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003, 4:1002-1012. 10.1038/nrn1256, 14618156.
8. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 2007, 27:684-691. 10.1523/JNEUROSCI.4595-06.2007, 17234600.
9. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 2000, 20:771-782.
10. Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, De Maeyer E, Murphy DL, Mossner R, Lesch KP, Hen R, Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci 2001, 21:884-96.
11. Bradley CC, Blakely RD. Alternative splicing of the human serotonin transporter gene. J Neurochem 1997, 69:1356-1367.
12. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grüsser SM, Flor H, Schumann G, Mann K, Büchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005, 8:20-21. 10.1038/nn1366, 15592465.
13. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834. 10.1038/nn1463, 15880108.
14. Watson C, Hoeft F, Garrett AS, Hall SS, Reiss AL. Aberrant brain activation during gaze processing in boys with fragile X syndrome. Arch Gen Psychiatry 2008, 65:1315-1323. 10.1001/archpsyc.65.11.1315, 18981343.
15. Meyer-Lindenberg A, Hariri AR, Munoz KE, Mervis CB, Mattay VS, Morris CA, Berman KF. Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci 2005, 8:991-993. 10.1038/nn1494, 16007084.
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531. 10.1126/science.274.5292.1527, 8929413.
17. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005, 29:8-16. 10.1097/01.ALC.0000150008.68473.62, 15654286.
18. Fallgatter AJ, Bartsch AJ, Herrmann MJ. Electrophysiological measurements of anterior cingulate function. J Neural Transm 2002, 109:977-988. 10.1007/s007020200080, 12111483.
19. Canli T, Lesch KP. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 2007, 10:1103-1109. 10.1038/nn1964, 17726476.
20. MacKenzie A, Quinn JA. serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999, 96:15251-15255. 10.1073/pnas.96.26.15251, 24806, 10611371.
21. Battersby S, Ogilvie AD, Blackwood DH, Shen S, Muqit MM, Muir WJ, Teague P, Goodwin GM, Harmar AJ. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene. J Neurochem 1999, 72:1384-1388. 10.1046/j.1471-4159.1999.721384.x, 10098839.
22. Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, Lesch KP, Lu B, Murphy DL. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005, 79:756-771. 10.1002/jnr.20410, 15672416.
23. Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG. Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem 2007, 101:641-651. 10.1111/j.1471-4159.2006.04392.x, 17254018.
24. Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996, 710:11-20. 10.1016/0006-8993(95)01289-3, 8963648.
25. Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, Nishiyama N, Matsuki N. Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 2002, 22:7580-7585.
26. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ, de Andrade M, Bower JH, Maraganore DM, Uhl GR. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet 2005, 134:93-103.
27. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66 met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269. 10.1016/S0092-8674(03)00035-7, 12553913.
28. Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, Rabbitt P, Pendleton N, Horan M, Payton A. Brain-derived neurotrophic factor polymorphism Val66 Met influences cognitive abilities in the elderly. Genes Brain Behav 2008, 7:411-417. 10.1111/j.1601-183X.2007.00363.x, 17973920.
29. Singh VK, Singh EA, Warren RP. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental deficiency. Biol Psychiatry 1997, 41:753-755. 10.1016/S0006-3223(96)00522-7, 9067002.
30. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental deficiency. Ann Neurol 2001, 49:597-606. 10.1002/ana.1024, 11357950.
31. Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Narita M. Serum neurotrophin concentrations in autism and mental deficiency: a pilot study. Brain Dev 2004, 26:292-295. 10.1016/S0387-7604(03)00168-2, 15165668.
32. Wendland JR, Martin BJ, Kruse MD, Lesch KP, Murphy DL. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 2006, 113:224-226.
33. Cook EH, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, Haas R, Courchesne E, Leventhal BL. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997, 2:247-250. 10.1038/sj.mp.4000266, 9152989.
34. Bland JM, Altman DG. Statistics Notes: The odds ratio. BMJ 2000, 320:1468. 10.1136/bmj.320.7247.1468, 1127651, 10827061.
35. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008, 33:73-83. 10.1038/sj.npp.1301571, 17882234.
36. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66:2621-2624.
37. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996, 1:453-460.
38. Eckert D, Buhl S, Weber S, Jager R, Schorle H. The AP-2 family of transcription factors. Genome Biol 2005, 6:246. 10.1186/gb-2005-6-13-246, 1414101, 16420676.
39. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78:815-826. 10.1086/503850, 1474042, 16642437.
40. Harris SE, Fox H, Wright AF, Hayward C, Starr JM, Whalley LJ, Deary IJ. The brain-derived neurotrophic factor Val66 Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry 2006, 11:505-513. 10.1038/sj.mp.4001799, 16446742.
41. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 397-406. 10.1016/j.ygeno.2007.05.004, 2568880, 17629449.
42. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, Krystal JH, Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006, 59:673-680. 10.1016/j.biopsych.2005.10.026, 16458264.
43. Hünnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP. Interaction between BDNF Val66 Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007, 32:2552-2560. 10.1038/sj.npp.1301383, 17392738.
44. Frodl T, Schüle C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM. Association of the brain-derived neurotrophic factor Val66 Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007, 64:410-416. 10.1001/archpsyc.64.4.410, 17404118.
45. Philibert R, Madan A, Andersen A, Cadoret R, Packer H, Sandhu H. Serotonin transporter MDNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet 2007, 144:101-105.
46. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007, 14:268-276. 10.1101/lm.500907, 2216532, 17522015.